miR-146a directly targets IRAK1 and TRAF6 which are the key adapter molecules in the TLR/NF-κB pathway in the model of cardiac ischemia and reperfusion (I/R) injury and monocytic cell-based endotoxin tolerance. The gene discussed is NFKB1; the disease is myocardial ischemia.